AstraZeneca and Vietnam Vaccine JSC (VNVC) have delivered an additional 1,547,100 doses of COVID-19 Vaccine AstraZeneca (also known as Vaxzevria) to Vietnam, reaching the milestone of 30 million doses and completing the first phase of the companies’ vaccine supply partnership, Read More …
Only antibody therapy authorised in US for pre-exposure prophylaxis Pivotal phase III data showed robust efficacy and long-term protection with one dose in high-risk population AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency Read More …
Vietnam Prime Minister and AstraZeneca CEO had bilateral telephone conversation today AstraZeneca delivered another 1,209,400 doses of its COVID-19 vaccine to Vietnam. The delivery is the ninth to Vietnam in total as part of the advance purchase agreement (APA) between Read More …
AstraZeneca delivered 592,100 additional doses of its COVID-19 vaccine for use in Vietnam on August 6th, 2021. The delivery is the seventh to Vietnam in total as part of the advance purchase agreement between AstraZeneca and Vietnam Vaccine JSC (VNVC), Read More …
Trial to enroll approximately 2,250 adults to assess safety and immunogenicity of AZD2816 against the SARS-CoV-2 virus The first participants in a Phase II/III trial for the new COVID-19 variant vaccine AZD2816 were vaccinated today to assess its safety and immunogenicity in both Read More …
Real-world data demonstrated 92% vaccine effectiveness against hospitalisations due to the Delta variant New data from Public Health England (PHE) demonstrated COVID-19 Vaccine AstraZeneca offers high levels of protection against the Delta variant (B.1.617.2; formerly the ‘Indian’ variant). Real world Read More …
